When is a carrier not a membrane carrier? The cytoplasmic transport of amphipathic molecules
- PMID: 8903412
- DOI: 10.1002/hep.510240550
When is a carrier not a membrane carrier? The cytoplasmic transport of amphipathic molecules
Abstract
After entering the cell, small molecules must penetrate the cytoplasm before they are metabolized, excreted, or can convey information to the cell nucleus. Without efficient cytoplasmic transport, most such molecules would efflux back out of the cell before they could reach their targets. Cytoplasmic movement of amphipathic molecules (e.g., long-chain fatty acids, bilirubin, bile acids) is greatly slowed by their tendency to bind intracellular structures. Soluble cytoplasmic binding proteins reduce this binding by increasing the aqueous solubility of their ligands. These soluble carriers catalyze the transport of hydrophobic molecules across hydrophilic water layers, just as membrane carriers catalyze the transport of hydrophilic molecules across the hydrophobic membrane core. They even display the kinetic features of carrier-mediated transport, including saturation, mutual competition between similar molecules, and countertransport. Recent data suggest that amphipathic molecules cross the cytoplasm very slowly, with apparent diffusion constants 10(2) to 10(4) times smaller than in water. By modulating the rate of cytoplasmic transport, cytosolic binding proteins may regulate transport and metabolism of amphipathic molecules. Storage diseases may cause hepatocellular dysfunction by disrupting normal cytoplasmic transport.
Similar articles
-
Transfer of fatty acids between intracellular membranes: roles of soluble binding proteins, distance, and time.Am J Physiol Gastrointest Liver Physiol. 2002 Jan;282(1):G105-15. doi: 10.1152/ajpgi.00238.2001. Am J Physiol Gastrointest Liver Physiol. 2002. PMID: 11751163
-
Intracellular transport of small hydrophobic compounds by the hepatocyte.Semin Liver Dis. 1996 May;16(2):159-67. doi: 10.1055/s-2007-1007229. Semin Liver Dis. 1996. PMID: 8781021 Review.
-
Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer.Life Sci. 2005 Aug 19;77(14):1605-11. doi: 10.1016/j.lfs.2005.05.008. Life Sci. 2005. PMID: 15964025
-
Examination of the role of intestinal fatty acid-binding protein in drug absorption using a parallel artificial membrane permeability assay.Chem Biol. 2007 Apr;14(4):453-65. doi: 10.1016/j.chembiol.2007.03.009. Chem Biol. 2007. PMID: 17462580
-
Transport of macromolecules between the nucleus and the cytoplasm.RNA. 1998 Apr;4(4):351-64. RNA. 1998. PMID: 9630243 Free PMC article. Review.
Cited by
-
Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism.Mol Cell Biochem. 2004 Apr;259(1-2):115-29. doi: 10.1023/b:mcbi.0000021357.97765.f2. Mol Cell Biochem. 2004. PMID: 15124915
-
Mechanisms of intracellular fatty acid transport: role of cytoplasmic-binding proteins.J Mol Neurosci. 2007 Sep;33(1):42-4. doi: 10.1007/s12031-007-0047-y. J Mol Neurosci. 2007. PMID: 17901544
-
Validation of Recombinant Chicken Liver Bile Acid Binding Protein as a Tool for Cholic Acid Hosting.Biomolecules. 2021 Apr 27;11(5):645. doi: 10.3390/biom11050645. Biomolecules. 2021. PMID: 33925706 Free PMC article.
-
Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.J Pharmacokinet Biopharm. 1999 Jun;27(3):233-56. doi: 10.1023/a:1020990912291. J Pharmacokinet Biopharm. 1999. PMID: 10728488
-
In vitro binding of lidocaine to liver tissue under the influence of propranolol: another mechanism of interaction?Eur J Drug Metab Pharmacokinet. 2007 Oct-Dec;32(4):213-7. doi: 10.1007/BF03191006. Eur J Drug Metab Pharmacokinet. 2007. PMID: 18348470
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources